JP2013541596A5 - - Google Patents

Download PDF

Info

Publication number
JP2013541596A5
JP2013541596A5 JP2013537923A JP2013537923A JP2013541596A5 JP 2013541596 A5 JP2013541596 A5 JP 2013541596A5 JP 2013537923 A JP2013537923 A JP 2013537923A JP 2013537923 A JP2013537923 A JP 2013537923A JP 2013541596 A5 JP2013541596 A5 JP 2013541596A5
Authority
JP
Japan
Prior art keywords
thiazole
diol
pyrano
tetrahydro
hydroxyethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013537923A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013541596A (ja
JP5965407B2 (ja
Filing date
Publication date
Priority claimed from PCT/CN2010/078528 external-priority patent/WO2012061972A1/en
Application filed filed Critical
Priority claimed from PCT/US2011/059668 external-priority patent/WO2012064680A1/en
Publication of JP2013541596A publication Critical patent/JP2013541596A/ja
Publication of JP2013541596A5 publication Critical patent/JP2013541596A5/ja
Application granted granted Critical
Publication of JP5965407B2 publication Critical patent/JP5965407B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013537923A 2010-11-08 2011-11-08 選択的グリコシダーゼ阻害薬およびその使用 Expired - Fee Related JP5965407B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
PCT/CN2010/078528 WO2012061972A1 (en) 2010-11-08 2010-11-08 Selective glycosidase inhibitors and uses thereof
CNPCT/CN2010/078528 2010-11-08
US41859610P 2010-12-01 2010-12-01
US61/418,596 2010-12-01
PCT/CN2011/080691 WO2012062157A1 (en) 2010-11-08 2011-10-12 Pyrano[3,2-d]thiazol derivatives and uses thereof as selective glycosidase inhibitors
CNPCT/CN2011/080691 2011-10-12
PCT/US2011/059668 WO2012064680A1 (en) 2010-11-08 2011-11-08 Selective glycosidase inhibitors and uses thereof

Publications (3)

Publication Number Publication Date
JP2013541596A JP2013541596A (ja) 2013-11-14
JP2013541596A5 true JP2013541596A5 (https=) 2014-12-25
JP5965407B2 JP5965407B2 (ja) 2016-08-03

Family

ID=46051261

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013537923A Expired - Fee Related JP5965407B2 (ja) 2010-11-08 2011-11-08 選択的グリコシダーゼ阻害薬およびその使用

Country Status (12)

Country Link
EP (1) EP2637503B1 (https=)
JP (1) JP5965407B2 (https=)
KR (1) KR101922266B1 (https=)
AR (1) AR083798A1 (https=)
AU (2) AU2011326186A1 (https=)
BR (1) BR112013011441B8 (https=)
CA (1) CA2816798C (https=)
ES (1) ES2600028T3 (https=)
MX (1) MX336611B (https=)
RU (1) RU2592285C2 (https=)
TW (1) TW201249848A (https=)
WO (1) WO2012064680A1 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2321289A4 (en) 2008-08-01 2011-11-16 Univ Fraser Simon SELECTIVE GLYCOSIDASE HEMMER AND ITS USE
WO2011140640A1 (en) 2010-05-11 2011-11-17 Simon Fraser University Selective glycosidase inhibitors and uses thereof
US8933040B2 (en) 2010-11-08 2015-01-13 Craig A. Coburn Selective glycosidase inhibitors and uses thereof
RU2609210C2 (ru) * 2010-12-23 2017-01-31 Алектос Терапьютикс Инк. Селективные ингибиторы гликозидазы и их применение
EP2688899B1 (en) 2011-03-24 2017-02-22 Alectos Therapeutics Inc. Selective glycosidase inhibitors and uses thereof
EP2691407B1 (en) 2011-03-31 2017-02-22 Alectos Therapeutics Inc. Selective glycosidase inhibitors and uses thereof
US9701693B2 (en) 2011-06-27 2017-07-11 Alectos Therapeutics Inc. Selective glycosidase inhibitors and uses thereof
EP2726468B1 (en) 2011-06-27 2017-04-12 Alectos Therapeutics Inc. Selective glycosidase inhibitors and uses thereof
BR112013033098B8 (pt) 2011-06-27 2021-03-23 Alectos Therapeutics Inc inibidores de glicosidade seletivos e usos dos mesmos
EP2847199B1 (en) * 2012-05-08 2017-10-25 Merck Sharp & Dohme Corp. Permeable glycosidase inhibitors and uses thereof
EP2890675A4 (en) 2012-08-31 2016-01-13 Alectos Therapeutics Inc GLYCOSIDASE INHIBITORS AND USES THEREOF
EP2890676B1 (en) 2012-08-31 2018-12-05 Alectos Therapeutics Inc. Glycosidase inhibitors and uses thereof
KR20150079711A (ko) * 2012-10-31 2015-07-08 알렉토스 테라퓨틱스 인크. 글리코시다아제 저해제 및 이의 용도
WO2014100934A1 (en) * 2012-12-24 2014-07-03 Merck Sharp & Dohme Corp. Glycosidase inhibitors and uses thereof
RU2748383C1 (ru) * 2020-10-21 2021-05-25 федеральное государственное автономное образовательное учреждение высшего образования "Казанский (Приволжский) федеральный университет" (ФГАОУ ВО КФУ) Способ терапии болезни Тея-Сакса и болезни Сандхоффа с помощью генетически модифицированных мезенхимных стволовых клеток человека со сверхэкспрессией β-гексозаминидазы A
WO2024083820A1 (en) 2022-10-18 2024-04-25 Institut National de la Santé et de la Recherche Médicale Method and composition for determining the level of o-glcnacylation in horses

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1441749A1 (ru) * 1987-03-16 1996-01-10 Институт Тонкой Органической Химии Им.А.Л.Мнджояна 2-АМИНО-5,5-ДИМЕТИЛ-4,5-ДИГИДРО-7Н-ПИРАНО [4,3-d] ТИАЗОЛ, ОБЛАДАЮЩИЙ ТРАНКВИЛИЗИРУЮЩЕЙ АКТИВНОСТЬЮ
CA2599843C (en) 2005-03-01 2013-08-27 Simon Fraser University Selective glycosidase inhibitors, methods of making inhibitors, and uses thereof
AU2007291870B2 (en) * 2006-08-31 2012-12-06 Simon Fraser University Selective glycosidase inhibitors and uses thereof
EP2321289A4 (en) 2008-08-01 2011-11-16 Univ Fraser Simon SELECTIVE GLYCOSIDASE HEMMER AND ITS USE
CA2732335A1 (en) 2008-08-01 2010-02-04 Simon Fraser University Selective glycosidase inhibitors and uses thereof
CA2737267A1 (en) 2008-09-16 2010-04-08 Simon Fraser University Selective glycosidase inhibitors and uses thereof
ES2568603T3 (es) * 2011-08-25 2016-05-03 Merck Patent Gmbh Pirano[3,2-d][1,3]tiazol como inhibidores de glicosidasas

Similar Documents

Publication Publication Date Title
JP2013541596A5 (https=)
RU2013126531A (ru) Селективные ингибиторы гликозидазы и их применение
JP2010501598A5 (https=)
JP2014501740A5 (https=)
JP2015534991A5 (https=)
RU2014102232A (ru) Селективные ингибиторы гликозидазы и их применение
RU2015120556A (ru) Ингибиторы гликозидаз и их применения
JP6218260B2 (ja) Jak阻害剤としてのアミノピリミジニル化合物
HRP20161079T1 (hr) Selektivni inhibitori glikozidaze i njihove uporabe
RU2678835C2 (ru) Агонисты мускариновых рецепторов
JP5657556B2 (ja) α7選択的リガンドを用いる治療
IL267215B (en) Imidazopyrrolopyridine as inhibitors of the jak family of kinases
JP6592510B2 (ja) P2x7調節因子
JP2013509392A5 (https=)
JP2012502884A5 (https=)
MX2015015893A (es) 2-fenilimidazo[1,2-a]pirimidinas como agentes formadores de imagen.
KR20100130240A (ko) 3­치환­2(아릴알킬)­1­아자바이시클로알칸 및 그 사용방법
WO2007140005A2 (en) Oxazolyl piperidine modulators of fatty acid amide hydrolase
BR112014015142B1 (pt) Di-hidropirimidinoisoquinolinonas, seus usos, e composição farmacêutica
JP2021528446A5 (https=)
ME02672B (me) Fenil-3-aza-bicikl0[3.1.0]heks-3-il-metanoni i njihova primena kao medikament
MX2015014353A (es) Derivados de 2-fenil- o 2-hetaril-imidazol[1,2-a]piridina.
AU2017376398A1 (en) Aminopyrazoles as selective janus kinase inhibitors
CN105189497B (zh) 作为janus激酶抑制剂的n-(2-氰基杂环基)吡唑并吡啶酮
JP2019537592A5 (https=)